Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Allergy Partners Discusses Complimentary and Alternative Medicines for Seasonal Allergies
  • USA - English


News provided by

Allergy Partners

Sep 06, 2018, 03:00 ET

Share this article

Share toX

Share this article

Share toX

SPRINGFIELD, Va. (PRWEB) September 06, 2018 -- As allergists, we are frequently asked about herbal, homeopathic, ayurvedic or non-medicine based treatments for seasonal allergies. These, as well as other non-traditional treatments, fall under the category of complementary and alternative medicines or “CAM” for short. CAM has been defined as a group of diverse medical and health care systems, practices and products that are not generally considered part of conventional medicine. Examples include natural products (i.e. herbs, probiotics), mind and body medicine (i.e. yoga, acupuncture), as well as manipulative and body-based practices (i.e. spinal manipulation, massage therapy). The 2007 National Health Interview Survey showed that approximately 38% of adults and 12% of children use CAM. Because of the increased use of these practices, the federal government created the Office of Alternative Medicine in 1991 that was re-established as the National Center for Complementary and Alternative Medicine (NCCAM) in 1998. Their mission is “to define, through rigorous scientific investigation, the usefulness and safety of complementary and alternative medicine interventions and their roles in improving health and health care.” The NCCAM is one of the 27 institutes and centers that make up the National Institutes of Health (NIH) within the Department of Health and Human Services. NCCAM has commented on the use of CAM for seasonal allergies that was the inspiration for this blog post. The different treatments include:

1. Natural Products
The herb butterbur may decrease allergy symptoms, but concerns have been raised about its safety. A randomized controlled trial of butterbur versus cetirizine (aka Zyrtec) from 2002 showed that the effects were similar for both treatments in terms of reducing symptoms of seasonal allergies. Regarding its safety, the raw, unprocessed butterbur plant contains chemicals called pyrrolizidine alkaloids (PAs). PAs can cause liver damage and can result in serious illness. Only butterbur products that have been processed to remove PAs and are labeled or certified as PA-free should be used. Several studies, including a few studies of children and adolescents, have reported that PA-free butterbur products are safe and well tolerated when taken by mouth in recommended doses for up to 12 to 16 weeks. The safety of longer-term use has not been established. Also, butterbur may cause allergic reactions in people who are sensitive to plants such as ragweed, chrysanthemums, marigolds and daisies.

Except for butterbur, herbs have not been shown to relieve seasonal allergy symptoms. Capsaicin, quercetin, and pine bark extract have not been proven to be helpful for seasonal allergies (although capsaicin nasal sprays have been shown to safely improve nasal symptoms in patients with non-allergic rhinitis). Chamomile and echinacea are two popular herbs that can cause allergic reactions in some people. Some herbs or other dietary supplements may interact with medications or have side effects of their own. Some dietary supplements may contain potentially harmful ingredients not listed on the label.

A general note of caution regarding dietary supplements; although these products are regulated through the Food and Drug Administration (FDA), the rules for dietary supplements are not the same as those for prescription or over-the-counter drugs. In general, the regulations for dietary supplements are less strict; for example, a manufacturer does not have to prove the safety and effectiveness of a dietary supplement before it is marketed. Once a dietary supplement is on the market, the FDA monitors safety and product information (label claims and package inserts), and the Federal Trade Commission (FTC) monitors advertising.

2. Acupuncture
A randomized control trial of acupuncture for allergies was published in 2013. They took over 400 patients with seasonal allergies and divided them into 3 treatment groups: one that received acupuncture, one that received sham (fake) acupuncture and one that received no acupuncture. Acupuncture led to statistically significant improvements in symptoms and antihistamine use after 8 weeks, but the improvements may not be significant because there was NO difference after 16 weeks. This study combined with a couple of others point towards the preliminary suggestion that the use of acupuncture for seasonal allergies has not been shown to incur any meaningful benefit

3. Local Honey
Many people believe that eating local honey will make them immune to pollen. The theory that eating so-called "natural" honey benefits those with allergies is purely anecdotal. There are several concerning issues related to the ingestion of honey for allergies. First, much of the pollen in honey is not the type that humans are allergic to (flowers and other blooming plants). Humans are normally allergic to tree, grass or weed pollen which is not contained in honey. Second, local honey likely contains many substances to which the patient is NOT allergic. Subsequently, a susceptible individual who frequently consumes honey may develop an allergy to these other substances. Anaphylactic allergic reactions to honey have been seen, so there are potentially serious risks associated with it. Finally, babies under the age of 1 should not be given honey, Clostridium botulinum spores in honey can grow in intestines and cause botulism poisoning.

4. Sinus Irrigation
Daily sinus irrigation (one type being neti pots) remains a potentially effective treatment for allergies and sinus infections in many patients. Washing the nasal cavities with saline reduces postnasal drainage, removes secretions and rinses away allergens/irritants. Sinus irrigation is associated with improvement in a variety of rhinitis conditions (with some studies showing benefits in children and pregnant women). Patients should use distilled, sterilized or previously boiled water with this strategy.

Unfortunately, there is a real lack of well-designed studies which makes it difficult for clinicians to recommend most CAM therapies with confidence. Patients who do wish to pursue CAM should consider the financial costs (which may be substantial) and be aware that long-term safety data on most of these therapies are lacking. For those patients who seek advice about what brand of herbal medicine to use, they can visit an independent source such as Consumer Labs which tests various brands of herbal therapies for content and quality.

Dr. Ananth Thyagarajan (Dr. T.)

Contact Information: 
Amanda Reed, Marketing and Corporate Communications Manager 
Allergy Partners, P.A. 
828-277-1300 phone 
828-277-2499 fax 
areed(at)allergypartners(dot)com 
https://www.allergypartners.com/ 
PR: NOVA MedMarket

Amanda Reed, Allergy Partners, http://www.allergypartners.com, +1 828.350.2162, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.